LENZ Therapeutics, Inc. (LENZ) at a glance
LENZ Therapeutics, Inc. (LENZ) is a micro-cap Healthcare company. It trades at $4.88, with a P/E of 48, a 97.8% profit margin and revenue growth of 19.7%. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Growth (78/100) and its weakest is Momentum (13/100). It carries above-market volatility, so expect larger swings.
- Price
- $4.88
- Market cap
- $212.3M
- P/E ratio
- 48.0
- Dividend yield
- None
- Beta
- 1.47
- 52-week range
- $4.54 to $50.40
Value
43
Growth
78
Income
40
Safety
40
Momentum
13
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield